Page:Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (N.D. Texas 2023).pdf/46

From Wikisource
Jump to navigation Jump to search
This page has been proofread, but needs to be validated.

Case 2:22-cv-00223-Z Document 137 Filed 04/07/23 Page 46 of 67 PageID 4468

vomiting and diarrhea during the actual abortion than did surgical patients … Post-abortion pain occurred in 77.1% of mifepristone patients compared with only 10.5% of surgical patients.” ECF No 1-13 at 24. And before the approval, an FDA medical officer recognized the “medical regimen had more adverse events, particularly bleeding, than did surgical abortion. Failure rates exceeded those for surgical abortion … This is a serious potential disadvantage of the medical method.” Id. at 23 (emphasis added).

Other studies show eighty-three percent of women report that chemical abortion “changed” them — and seventy-seven percent of those women reported a negative change.[1] Thirty-eight percent of women reported issues with anxiety, depression, drug abuse, and suicidal thoughts because of the chemical abortion.[2] Bleeding from a chemical abortion, unlike surgical abortion, can last up to several weeks.[3] And the mother seeing the aborted human “appears to be a difficult aspect of the medical termination process which can be distressing, bring home the reality of the event and may influence later emotional adaptation.”[4] “For example, one woman was surprised and saddened to see that her aborted baby ‘had a head, hands, and legs’ with ‘[d]efined fingers and toes.’” ECF No. 1 at 21. The entire abortion process takes place within the mother’s home, without physician oversight, potentially leading to undetected ectopic pregnancies, failure of rH factor incompatibility detection, and misdiagnosis of gestational age — all leading to severe or even fatal


  1. See Katherine A. Rafferty & Tessa Longbons, #AbortionChangesYou: A Case Study to Understand the Communicative Tensions in Women’s Medication Abortion Narratives, 36 Health Comm. 1485, 1485–94 (2021), https://www.tandfonline.com/doi/full/10.1080/10410236.2020.1770507.
  2. Id.
  3. After Mifepristone: When bleeding will start and how long will it last?, Women on Web, https://www.womenonweb.org/en/page/484/when-will-you-start-bleeding-and-howlong-will-it-last. See also ECF No. 1-28 at 25 (“Up to 8% of all subjects may experience some type of bleeding for 30 days or more.”).
  4. Pauline Slade et al., Termination of Pregnancy: Patient’s Perception of Care, 27 J. of Family Planning & Reproductive Health Care 72, 76 (2001).

46